New Pain Relief Hope from Cone Snail Venom

Topic: Health

Scientists have found a new peptide in cone snail venom that can help reduce pain without using opioids. The team led by Harald Sitte from the Medical University of Vienna discovered this peptide, AoIA, which can be injected under the skin to relieve pain caused by inflammation.

An international research team has made an exciting discovery about a new peptide in cone snail venom that could help people manage pain without using opioids. The team, led by Harald Sitte from the Medical University of Vienna, found this peptide, called AoIA, which can be injected under the skin to relieve pain caused by inflammation.

This is important because opioids are often used to treat pain, but they come with serious risks, such as addiction and overdose. The team's discovery provides a new hope for developing non-opioid pain medications that are easier to administer.

The researchers studied AoIA in an animal model and found that it significantly reduced inflammation-induced pain immediately after injection. This is a significant improvement over previous cone snail peptides, which had to be administered directly into the cerebrospinal fluid. The team also determined the three-dimensional structure of the human norepinephrine transporter bound to AoIA using cryo-electron microscopy.

This understanding of how AoIA works will help scientists develop new pain medications that target the same mechanism. The peptide does not act on opioid receptors or other known targets involved in pain processing, making it a promising approach for developing new active substances.

Why It Matters

This discovery could lead to new pain relief options for people suffering from chronic pain without the risks associated with opioids. It's also an example of how scientists are working to find alternative solutions to manage pain and improve human health.

Key Facts

• The peptide AoIA was discovered in cone snail venom and can be injected under the skin to relieve pain caused by inflammation.
• AoIA significantly reduced inflammation-induced pain immediately after injection in an animal model.
• The team determined the three-dimensional structure of the human norepinephrine transporter bound to AoIA using cryo-electron microscopy.
• AoIA does not act on opioid receptors or other known targets involved in pain processing, making it a promising approach for developing new active substances.
• The study was published in the journal Nature Structural & Molecular Biology.

Key Terms

Norepinephrine transporter

A protein that helps regulate the amount of norepinephrine in the body, which is involved in pain processing.

Implications

This discovery could lead to new pain relief options for people suffering from chronic pain without the risks associated with opioids. It's also an example of how scientists are working to find alternative solutions to manage pain and improve human health.